W

West Houston Area Clinical Trial Consultants | Katy Cardiology Associates - Katy, TX

Research site
(Unclaimed)
Location
1331 W Grand Parkway N Suite 130, Katy, Texas, United States of America

Site insights

Top conditions

Top treatments

Obicetrapib
Apixaban

Parent organization

This site is a part of West Houston Area Clinical Trial Consultants

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Placebo
Drug: Apixaban Placebo

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

Trial sponsors

J
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems